The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
✍ Scribed by Jördis J Ott, Gretchen A Stevens, Steven T Wiersma
- Book ID
- 119896298
- Publisher
- BioMed Central
- Year
- 2012
- Tongue
- English
- Weight
- 213 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1471-2334
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Factors influencing and predictive of seroconversion from hepatitis B e antigen (HBeAg) to antibody (anti‐HBe) were sought in a case‐control study of 61 patients with chronic hepatitis B who had been observed from 5 years before to 1 year after seroconversion, and 32 patients who did no
A randomized double-blind, placebo-controlled efficacy trial of hepatitis B immune globulin (HBIG) for prevention of the mother-to-infant transmitted HBsAg carrier state was conducted in Taiwan where the carrier rate in the general population is 15 to 20%. HBIG was given immediately after birth to i